Stocklytics score rationale: value 15, quality 63, growth 61.
Financials
2023
2024
2025
292730000
390404000
587860000
Established in 2012 and headquartered in San Francisco, California, Hinge Health, Inc. creates specialized healthcare software solutions for musculoskeletal and joint health. Their advanced platform is designed to comprehensively manage a spectrum of needs, including general musculoskeletal care, acute injuries, persistent chronic pain, and post-operative rehabilitation. Furthermore, the company provides essential…
Forecast
Consensus Buy from 17 analysts. Average price target $103.92, -11.3% versus the current price. Low $76.00. High $140.00.
Analysts have an average 12-month price target of $103.92 for Hinge Health (HNGE), 11.3% below the current price of $117.10. Of 17 analysts covering the stock, 16 rate it Buy or Strong Buy, 1 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
HNGE price target
12-month price target
Low
$76.00
Average
$103.92
High
$140.00
The average is 11.3% below the current price of $117.10.
Is Hinge Health a buy or sell?
Of 17 analysts, 16 rate Hinge Health Buy or Strong Buy, 1 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
The Stocklytics Score for HNGE is 46 out of 100. It averages value, quality, and growth against a large-cap US universe. It is not a price target and not a buy or sell rating. Fair value is a separate estimate on the fair value tab.
HNGE forecast FAQs
What is the HNGE price target?
$103.92 average, with a published range of $76.00 to $140.00.
Is Hinge Health a buy or sell?
The consensus is Buy from 17 analysts. This is not a recommendation.
What is the Hinge Health stock forecast for 2026?
Analysts' average EPS estimate for 2026 on file is $2.32. The average revenue estimate is $860.59 million.
What will HNGE be worth in 2030?
No reliable forecast exists that far out.
When is Hinge Health's next earnings report?
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.